Inscrição YC de Gamgee

Summer 2026Active

San Francisco

Gamgee passou pela Y Combinator no batch Summer 2026 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.

Batch YC: Summer 2026
Indústria: HealthcareDrug Discovery and Delivery
Localização: San Francisco
Tamanho da equipe: 2
Status: Active
Lançada: 2026

Fundadores

Paul ConynghamFounder/CEO

O que Gamgee faz

Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next

Inscrição YC de Gamgee, reconstruída

Inscrição Y Combinator

Gamgee, lote Summer 2026. As verdadeiras perguntas do formulário, respondidas com dados públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Gamgee

Describe what your company does in 50 characters or less.

Personalised mRNA cancer vaccines for dogs.

What is your company going to make? Please describe your product and what it does or will do.

We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.

Where do you live now, and where would the company be based after YC?

San Francisco, CA, USA; Remote. The company would remain based there after YC.

Explain your decision regarding location.

San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.

21 respostas a mais na inscrição completa

Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.

Ver inscrição completa

Perguntas Frequentes

Esta é a inscrição real da YC de Gamgee?

Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Gamgee (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Gamgee se apresentaria à YC, não o texto que eles submeteram.

Em qual batch da YC Gamgee esteve?

Gamgee fez parte do batch Summer 2026 da Y Combinator.

Quem fundou o Gamgee?

O Gamgee foi fundado por Paul Conyngham.

O que o Gamgee faz?

Curing cancer. Starting with dogs.

Como eu leio o application completo reconstruído?

Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Gamgee, e de todos os outros lotes do YC, está no YC Insights.